IJCBPI homepage

Current Issue

Vol. 1 No. 1 (2026): Inaugural Issue
IJCBPI - Vol. 1 No. 1 (2026) issue cover

Published on 10 October 2026 as the inaugural issue of the International Journal of Convergent Biosciences and Pharmaceutical Innovation (IJCBPI), the sixth title of International Journal Press. Two double-blind peer-reviewed articles announce the journal's convergence brief. The first surveys single-walled carbon nanohorns — their structure, functionalisation chemistry and emerging applications in drug delivery, biosensing and energy storage — as a versatile nanocarbon platform. The second reviews herbal medicines in perioperative care, tracing herb-drug interactions and bleeding risk into a risk-stratified medication-reconciliation framework for anaesthesia and surgery. The speciality of the inaugural issue is that it links materials science to clinical pharmacy: a nanomaterial platform paper and a patient-safety paper that meet in the space between biological discovery and pharmaceutical practice, the interface the journal was created to publish.

Published: 10-10-2026

Articles

View All Issues

IJCBPI · Open-access · Peer-reviewed · Published monthly

Research where biological discovery and pharmaceutical development converge.

IJCBPI publishes scholarship on translational bioscience, pharmaceutical innovation, and bioinformatics, with rigorous double-blind peer review and a scope-first editorial process designed to give authors candid, timely decisions.

Submit Manuscript Author Guidelines

Journal at a Glance

29th
Submission deadline (every month)
4-5 days
First editorial decision
7 days
Peer review
5 days
Submission to acceptance
15 days
Acceptance to publication
34%
Acceptance rate

Typical editorial timelines; actual times vary with submission volume and reviewer availability.

Scope

Translational bioscience

Moving discovery from bench toward therapeutic impact.

Pharmaceutical innovation

Formulation, delivery, and the science of new medicines.

Bioinformatics & computational biology

Data-driven methods across the life sciences.

Drug discovery & convergent methods

Cross-disciplinary pipelines from target to candidate.

Why publish with IJCBPI?

  • Double-blind peer review with transparent editorial checks and reasoned decisions.
  • Open access from day one under CC BY 4.0, no paywalls, no embargo.
  • Scope-first triage: fast, candid early decisions.
  • Indexing-ready workflow: DOI, ORCID, and OAI-PMH from issue one.

ISSN (Online): pending · CC BY 4.0 · OAI-PMH enabled · Editorial contact: [email protected]